Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with mild to moderate essential hypertension and whose medical condition make them eligible for treatment with Telmisartan/Telmisartan+HCTZ
You may not be if
Pre-menopausal women who had had no birth control, who are pregnant or nursing
Patients with advanced hepatic impairment, advanced renal impairment or both
Patients with functional class III or IV (NYHA) congestive heart failure (CHF), unstable angina, acute myocardial infarction, heart surgery or stroke within the previous six months
Patients with any valvular disease with hemodynamic repercussion
Patients receiving chronic administration of oral anticoagulants or digoxin
Patients with known hypersensitivity to any component in the formulation of Micardis / MicardisPlus
Patients with previous history of angioedema associated with ACE inhibitors
Patients with severe, uncontrolled hypertension or any form of secondary hypertension
Patients with any other clinical conditions which, in the opinion of the investigator, would not allow for the safe completion of the protocol
Clareo Health | Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
